Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Receivables - Net (2023 - 2024)

Historic Receivables - Net for Capricor Therapeutics (CAPR) over the last 3 years, with Q4 2024 value amounting to $10.0 million.

  • Capricor Therapeutics' Receivables - Net changed 0.0% to $10.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.0 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Capricor Therapeutics reported Receivables - Net of $10.0 million as of Q4 2024, which was down 0.0% from $10.0 million recorded in Q4 2023.
  • In the past 5 years, Capricor Therapeutics' Receivables - Net ranged from a high of $10.0 million in Q4 2023 and a low of $10.0 million during Q4 2023